Drug Shortage Report for FUROSEMIDE INJ USP

Last updated on 2017-04-19 History
Report ID 2574
Drug Identification Number 00527033
Brand name FUROSEMIDE INJ USP
Common or Proper name FUROSEMIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) FUROSEMIDE
Strength(s) 10MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10 X 4ML
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-03-14
Estimated end date 2017-06-30
Actual end date 2017-04-18
Shortage status Resolved
Updated date 2017-04-19
Company comments Stock available at some wholesalers/Inventaire disponible chez certains grossistes
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2017-04-19 English Compare
v9 2017-04-18 French Compare
v8 2017-04-18 English Compare
v7 2017-03-28 French Compare
v6 2017-03-28 English Compare
v5 2017-03-21 French Compare
v4 2017-03-21 English Compare
v3 2017-03-15 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare

Showing 1 to 10 of 10